Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 321 Records) |
Query Trace: TYMS[original query] |
---|
Gene Polymorphisms Involved in Folate Metabolism and DNA Methylation with the Risk of Head and Neck Cancer. Asian Pacific journal of cancer prevention : APJCP 2020 Dec 21 (12): 3751-3759. De Castro Tialfi Bergamin, Rodrigues-Fleming Gabriela Helena, Oliveira-Cucolo Juliana Garcia De, Silva Jéssika Nunes Gomes Da, Silva Fabia Pigatti, Raposo Luiz Sérgio, Maniglia José Victor, Pavarino Erika Cristina, Batista Arantes Lidia Maria Rebolho, Galbiatti-Dias Ana Lívia Silva, Maria Goloni Bertollo E |
One-carbon metabolism and global DNA methylation in mothers of individuals with Down syndrome. Human cell 2021 8 34 (6): 1671-1681. Mendes Cristiani Cortez, Zampieri Bruna Lancia, Arantes Lidia Maria Rebolho Batista, Melendez Matias Eliseo, Biselli Joice Matos, Carvalho André Lopes, Eberlin Marcos Nogueira, Riccio Maria Francesca, Vannucchi Hélio, Carvalho Valdemir Melechco, Goloni-Bertollo Eny Maria, Pavarino Érika Cristi |
Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients. Clinical and experimental medicine 2021 Jul . Abdel Allah Hany M M, Zahran Walid E, El-Masry Samir A, El-Bendary Mahmoud, Soliman Ahmed |
3'-UTR Polymorphisms in Thymidylate Synthase with Colorectal Cancer Prevalence and Prognosis. Journal of personalized medicine 2021 Jun 11 (6): . Jeon Young-Joo, Cho Sung-Hwan, Kim Eo-Jin, Ryu Chang-Soo, Park Han-Sung, Kim Jong-Woo, Lee Jeong-Yong, An Hui-Jeong, Kim Nam-Ke |
Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine based chemotherapy toxicity. Pharmacogenomics 2021 . Ioannou Charalampia, Ragia Georgia, Balgkouranidou Ioanna, Xenidis Nikolaos, Amarantidis Kyriakos, Koukaki Triantafyllia, Biziota Eirini, Kakolyris Stylianos, Manolopoulos Vangelis |
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics 2021 Jun . Patel Jai N, Jiang Chen, Owzar Kouros, Mulkey Flora, Luzum Jasmine A, Mamon Harvey J, Haller Daniel G, Dragovich Tomislav, Alberts Steven R, Bjarnason Georg, Willet Christopher G, Niedzwiecki Donna, Enzinger Peter, Ratain Mark J, Fuchs Charles, McLeod Howard |
Association between 5'-UTR and 3'-UTR Polymorphisms of the TYMS Gene and Breast Cancer in Kurdish Women of Iraq. Asian Pacific journal of cancer prevention : APJCP 2021 May 22 (5): 1557-1560. Mohamad Kazhal She |
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes. The pharmacogenomics journal 2021 Mar . O'Connell E, Reynolds I S, Salvucci M, McNamara D A, Burke J P, Prehn J H |
The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens. The pharmacogenomics journal 2021 Feb . Khushman Moh'd, Patel Girijesh Kumar, Maharjan Anu Singh, McMillin Gwendolyn A, Nelson Cindy, Hosein Peter, Singh Ajay |
Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low. Breast cancer research and treatment 2021 Feb . Cao Shang, Zhu Zheng, Zhou Jinyi, Li Wei, Dong Yunqiu, Qian Yun, Wei Pingmin, Wu Mi |
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis. Frontiers in pharmacology 2021 12 757464. Song Zaiwei, Hu Yang, Liu Shuang, Jiang Dan, Yi Zhanmiao, Benjamin Mason M, Zhao Rongshe |
A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer. Experimental biology and medicine (Maywood, N.J.) 2021 10 247 (2): 120-130. Chen Qiangda, Pu Ning, Yin Hanlin, Zhang Jicheng, Zhao Guochao, Lou Wenhui, Wu Wenchu |
Variants of Genes Involved in Metabolism of Folate Among Patients with Breast Cancer: Association of TYMS 3R Allele with Susceptibility to Breast Cancer and Metastasis. Iranian journal of pathology 2021 16 (1): 62-68. Rahimi Zohreh, Bozorgi Zarini Maryam, Rahimi Ziba, Shakiba Ebrahim, Vaisi-Raygani Asad, Moradi Mohammad Taher, Yari Kheirol |
DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients. Journal of chemotherapy (Florence, Italy) 2022 Sep 1-10. Khalij Yassine, Belaid Imtinen, Chouchane Sana, Amor Dorra, Omezzine Asma, Ben Rejeb Nabila, Ben Ahmed Slim, Bouslama A |
Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. American journal of human genetics 2022 8 109 (8): 1472-1483. Tummala Hemanth, Walne Amanda, Buccafusca Roberto, Alnajar Jenna, Szabo Anita, Robinson Peter, McConkie-Rosell Allyn, Wilson Meredith, Crowley Suzanne, Kinsler Veronica, Ewins Anna-Maria, Madapura Pradeepa M, Patel Manthan, Pontikos Nikolas, Codd Veryan, Vulliamy Tom, Dokal Inderje |
A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. Frontiers in endocrinology 2022 8 13 975623. Wang Yuliang, Fan Jiaqi, Chen Tao, Xu Lele, Liu Pengyu, Xiao Lijia, Wu Tao, Zhou Qingchun, Zheng Qingyou, Liu Chunxiao, Chan Franky Leung, Wu Dingl |
Relationships between Maternal Gene Polymorphisms in One Carbon Metabolism and Adverse Pregnancy Outcomes: A Prospective Mother and Child Cohort Study in China. Nutrients 2022 May 14 (10): . Wang Shuxia, Duan Yifan, Jiang Shan, Bi Ye, Pang Xuehong, Liu Changqing, Yang Zhenyu, Lai Jianqia |
Genetic Markers of Therapeutic Efficacy of Methotrexate in Patients with Psoriasis. Bulletin of experimental biology and medicine 2022 2 172 (4): 460-463. Voron'ko O E, Baskaev K K, Sobolev V V, Denisova E V, Korsunskaya I |
Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients. Cancer chemotherapy and pharmacology 2022 Mar 89 (3): 393-400. Ramalingam Ravi, Kaur Harpreet, Scott Julius Xavier, Sneha Latha M, Arunkumar Ganeshprasad, Srinivasan Arathi, Paul Solomon F |
Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. The pharmacogenomics journal 2022 Jan . Lopes Guilherme S, Lopes Jaime L, Bielinski Suzette J, Armasu Sebastian M, Zhu Ye, Cavanaugh Dana C, Moyer Ann M, Jacobson Debra J, Wang Liwei, Jiang Ruoxiang, St Sauver Jennifer L, Larson Nicholas |
TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients. Pharmaceutics 2021 Dec 14 (1): . Emelyanova Marina, Pokataev Ilya, Shashkov Igor, Kopantseva Elena, Lyadov Vladimir, Heydarov Rustam, Mikhailovich Vladim |
Prediction of lung cancer risk in Chinese population with genetic-environment factor using extreme gradient boosting. Cancer medicine 2022 May . Li Yutao, Zou Zixiu, Gao Zhunyi, Wang Yi, Xiao Man, Xu Chang, Jiang Gengxi, Wang Haijian, Jin Li, Wang Jiucun, Wang Huai Zhou, Guo Shicheng, Wu Junj |
Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features. Journal of molecular neuroscience : MN 2023 4 . Maimaiti Aierpati, Liu Yanwen, Abulaiti Aimitaji, Wang Xixian, Feng Zhaohai, Wang Jiaming, Mijiti Maimaitili, Turhon Mirzat, Alimu Nilipaer, Wang Yongxin, Liang Wenbao, Jiang Lei, Pei Yin |
The role of gender pharmacogenetics in the personalization of drug treatment. The Journal of pharmacology and experimental therapeutics 2023 3 . Cecchin Erika, Posocco Bianca, Mezzalira Silvia, Appetecchia Marialuisa, Toffoli Giusep |
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
Thymidylate Synthase (TYMS) and Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms Associated With Severe Capecitabine Toxicity: The First Case From Saudi Arabia. Cureus 2023 12 15 (11): e49215. Nedal Bukhari, Hani Al-Mohanna, Fahad Almsn |
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer. Cancer chemotherapy and pharmacology 2023 10 . Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An |
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece. Frontiers in pharmacology 2023 10 14 1248898. Georgia Ragia, Anthi Maslarinou, Natalia Atzemian, Eirini Biziota, Triantafyllia Koukaki, Charalampia Ioannou, Ioanna Balgkouranidou, George Kolios, Stylianos Kakolyris, Nikolaos Xenidis, Kyriakos Amarantidis, Vangelis G Manolopoul |
Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer. International journal of molecular sciences 2024 1 25 (1): . Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 03, 2024
- Content source: